Graf Akcie MMSI (Merit Medical Systems, Inc.). Diskuze k akciím MMSI. Aktuální informace MMSI.

Základní informace o společnosti Merit Medical Systems, Inc. (Akcie MMSI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 3.98B
Hodnota podniku (EV) 4.21B
Tržby 1.031B
EBITDA 171.616M
Zisk 28.243M
Růst v tržbách Q/Q 28.37 %
Růst v tržbách Y/Y 7.10 %
P/E (Cena vůči ziskům) 136.71
Forward P/E 0.43
EV/Sales 4.08
EV/EBITDA 24.53
EV/EBIT 111.72
PEG 3.48
Price/Sales 3.93
P/FCF 29.70
Price/Book 4.23
Účetní hodnota na akcii 16.82
Hotovost na akcii 1.00
FCF vůči ceně 3.37 %
Počet zaměstnanců 5,989
Tržba na zaměstnance 172.185k
Profit margin -1.02 %
Operating margin 3.80 %
Gross margin 41.62 %
EBIT margin 3.65 %
EBITDA margin 16.64 %
EPS - Zisk na akcii 0.52
EPS - Kvartální růst 100.00 %
EPS - Očekávaný růst příští rok 4.76 %
Return on assets 1.70 %
Return on equity 2.93 %
ROIC -0.19 %
ROCE 2.63 %
Dluhy/Equity 0.74
Čistý dluh/EBITDA 8.25
Current ratio 2.14
Quick Ratio 1.21
Volatilita 2.35
Beta 0.96
RSI 47.32
Cílová cena analytiků 61
Známka akcie (dle analytiků) 1.89
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 56.271M
Procento shortovaných akcií 4.93 %
Short ratio 7.95 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1990
Země United States

Finanční výsledky akcie MMSI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$963.875$994.852$882.753$727.852$603.838$542.149
Cost Of Goods Sold$562.698$562.486$487.983$401.599$338.813$306.368
Gross Profit$401.177$432.366$394.77$326.253$265.025$235.781
Research And Development Expenses$57.537$65.615$59.532$51.403$45.229$40.81
SG&A Expenses$297.724$327.274$276.018$229.134$184.398$156.348
Other Operating Income Or Expenses$-47.228$0.232$0.698$0.298$-0.061$-0.08
Operating Expenses$965.437$979.418$824.136$694.783$568.962$504.606
Operating Income$-1.562$15.434$58.617$33.069$34.876$37.543
Total Non-Operating Income/Expense$-11.669$-13.241$-9.098$2.812$-9.49$-6.343
Pre-Tax Income$-13.231$2.193$49.519$35.881$25.386$31.2
Income Taxes$-3.388$-3.258$7.502$8.358$5.265$7.398
Income After Taxes$-9.843$5.451$42.017$27.523$20.121$23.802
Other Income------
Income From Continuous Operations$-9.843$5.451$42.017$27.523$20.121$23.802
Income From Discontinued Operations------
Net Income$-9.843$5.451$42.017$27.523$20.121$23.802
EBITDA$-1.562$120.372$128.825$87.189$79.413$75.784
EBIT$-1.562$15.434$58.617$33.069$34.876$37.543
Basic Shares Outstanding555552494444
Shares Outstanding555654504545
Basic EPS$-0.18$0.10$0.80$0.56$0.45$0.54
EPS - Earnings Per Share$-0.18$0.10$0.78$0.55$0.45$0.53
# 2020 2019 2018 2017 2016 2015
Current Ratio2.50222.45142.73412.75582.32062.5499
Long-term Debt / Capital0.31260.28570.27690.38690.29770.3301
Debt/Equity Ratio0.46260.42360.41170.65110.44540.5158
Gross Margin43.460344.720344.824143.890143.490144.1881
Operating Margin1.55146.64034.54345.77576.92487.8805
EBIT Margin1.55146.64034.54345.77576.92487.8805
EBITDA Margin12.099514.593611.97913.151413.978415.089
Pre-Tax Profit Margin0.22045.60964.92974.20415.75496.1944
Net Profit Margin0.54794.75983.78143.33224.39034.5075
Asset Turnover0.56610.54490.65470.64050.69620.6822
Inventory Turnover Ratio2.49222.47042.58622.80722.89033.0997
Receiveable Turnover5.78325.74666.09596.77626.67936.229
Days Sales In Receivables63.113363.515859.876753.865254.646158.5968
ROE - Return On Equity0.57384.50454.06944.03885.10665.2782
Return On Tangible Equity3.599531.209513.052619.428413.816116.3531
ROA - Return On Assets0.31022.59362.47552.13423.05653.0748
ROI - Return On Investment0.39443.21742.94252.47623.58633.5358
Book Value Per Share17.205116.992613.459911.158910.52949.9798
Operating Cash Flow Per Share-0.22080.35250.0572-0.36570.33210.0304
Free Cash Flow Per Share-0.4214-0.05010.01830.01960.00030.6303